For all the attention on U.S.-China AI competition, new studies point to China's rapid rise in biotechnology, especially for ...

China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

A dual-track approach has gained momentum for biotech companies as capital markets remain volatile and acquirers become more ...

Vera Therapeutics stock rocketed nearly 70% on Monday on upbeat data for a kidney-disease trial. Shares are tumbling Friday ...

The Japanese biotech behind Eli Lilly’s new blockbuster obesity pill believes it could be used with an anti-muscle wasting drug it has developed to create a new standard of patient care for weight ...

The investment bank says funding was down 57% last month, to $2.7 billion, and argues the new administration’s FDA ...

After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.

A new report from Pitchbook suggests we’re in for a period of more sustainable investing, with VC firms continuing to create ...

For investors still seeking companiies with attractive long-term prospects, let's consider two in the biotech industry: ...

The scheme will facilitate the creation of 50,000 urban infrastructure projects and generate wage employment for over five ...

With finite natural resources and a growing demand for food, the world must find ways to overcome this challenge. One ...

Brooklyn's business park in Sunset Park, Industry City, continues to see tenant demand. Biotech firms Cresilon and Rumi ...